Skip to main content
. 2023 Jul-Sep;27(3):428–435. doi: 10.5935/1518-0557.20220074

Table 4.

Clinical characteristics, hormonal profile and reproductive outcomes of normoovulatory infertile women according to rs4886238:G>A variant of the TDRD3 gene.

Variables Genotypes TDRD3 rs4886238:G>A p-value
GG GA AA
N 79 59 11 -
Age (years) 33.0 (32.0-34.0) 32.0 (31.0-33.5) 33.0 (29.7-36.0) 0.943a
BMI (kg/m2) 23.4 (23.0-24.4) 24.2 (22.8-25.0) 25.3 (22.9-27.5) 0.363a
Menarche (years old) 13.0 (12.0-13.0) 13.0 (12.0-13.0) 13.0 (11.4-14.0) 0.873a
Menstrual cycle interval (days) 28.0 (28.0-29.0) 28.0 (28.0-29.0) 29.0 (27.4-30.0) 0.859a
Infertility duration (years) 3.0 (3.0-4.0) 3.0 (3.0-4.0) 3.0 (2.0-6.3) 0.946a
FSH (UI/mL) 6.1 (5.7-6.8) 6.0 (5.7-6.4) 6.2 (4.2-7.3) 0.888a
LH (UI/mL) 3.0 (2.7-3.4) 2.9 (2.6-3.3) 2.8 (2.1-3.4) 0.826a
Progesterone (ng/mL) 8.1 (3.7-11.0) 5.8 (2.0-10.8) 7.3 (1.0-13.2) 0.868a
Prolactin (ng/mL) 14.8 (12.4-16.9) 16.9 (14.0-19.4) 18.9 (9.0-24.9) 0.377a
AMH (ng/mL) 2.8 (2.0-3.6) 3.4 (3.0-4.9) 4.5 (1.7-7.9) 0.025a
AFC 9 (8.0-10.0) 9.0 (8.0-10.0) 9.0 (7.7 -12.4) 0.858a
COS protocol (n, %)
100 UI
150 UI
200 UI
39 (49.4%)
7 (8.9%)
33 (41.8%)
28 (47.5%)
9 (15.2%)
22 (37.3%)
6 (54.5%)
1 (9.1%)
4 (36.3%)
0.814b
Response to COS (n, %)
Poor
Satisfactory
Hyper-response
16 (20.2%)
51 (64.5%)
12 (15.2%)
11 (18.6%)
41 (69.5%)
7 (11.8%)
5 (45.4%)
5 (45.4%)
1 (9.1%)
0.343b
Oocytes retrieved 5.0 (5.0-7.0) 6.0 (5.0-9.0) 4.0 (0.0-6.3) 0.139a
MII Oocytes 6.0 (4.0-6.7) 5.0 (4.0-7.5) 4.0 (0.0-6.0) 0.201a
Embryos 2.0 (2.0-4.0) 3.0 (2.0-4.0) 2.0 (0.0-3.3) 0.182a
Pregnancy rate (n, %) 24 (30.4%) 21 (35.6%) 1 (9.1%) 0.215b

The variables were shown as median and CI (95%): 95% Confidence Interval; BMI: body mass index; COH: controlled ovarian hyperstimulation; FSH: follicle stimulating hormone; LH: luteinizing hormone; AMH: anti-Müllerian hormone; AFC: antral follicle counting; MII: oocytes metaphasis II.

a

Mann-Whitney Test and

b

Chi-squared test.